ATE70449T1 - Zusammensetzungen von katecholischen butanen mit zink. - Google Patents

Zusammensetzungen von katecholischen butanen mit zink.

Info

Publication number
ATE70449T1
ATE70449T1 AT87907401T AT87907401T ATE70449T1 AT E70449 T1 ATE70449 T1 AT E70449T1 AT 87907401 T AT87907401 T AT 87907401T AT 87907401 T AT87907401 T AT 87907401T AT E70449 T1 ATE70449 T1 AT E70449T1
Authority
AT
Austria
Prior art keywords
zinc
compositions
catecholic
catecholic butanes
new compositions
Prior art date
Application number
AT87907401T
Other languages
English (en)
Inventor
Russell T Jordan
Original Assignee
Chemex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemex Pharmaceuticals Inc filed Critical Chemex Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE70449T1 publication Critical patent/ATE70449T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87907401T 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink. ATE70449T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/924,620 US4880637A (en) 1985-02-11 1986-10-28 Compositions of catecholic butanes with zinc
EP87907401A EP0288534B1 (de) 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink
PCT/US1987/002868 WO1988003026A1 (en) 1986-10-28 1987-10-27 Compositions of catecholic butanes with zinc

Publications (1)

Publication Number Publication Date
ATE70449T1 true ATE70449T1 (de) 1992-01-15

Family

ID=25450444

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907401T ATE70449T1 (de) 1986-10-28 1987-10-27 Zusammensetzungen von katecholischen butanen mit zink.

Country Status (8)

Country Link
US (1) US4880637A (de)
EP (1) EP0288534B1 (de)
JP (1) JPH01501794A (de)
KR (1) KR880701556A (de)
AT (1) ATE70449T1 (de)
AU (1) AU616641B2 (de)
DE (1) DE3775387D1 (de)
WO (1) WO1988003026A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501791A (ja) * 1986-11-19 1989-06-22 ケメックス　ファーマシューティカルズ，インコーポレイティド 薬理学的に活性な化合物およびそれらの混合物、有機組成物および金属塩類
US6046243A (en) * 1993-02-12 2000-04-04 Bernard Technologies, Inc. Compositions for sustained release of a gas
US5409690A (en) * 1993-06-23 1995-04-25 Chemex Pharmaceuticals, Inc. Treatment of multidrug resistant diseases in cancer cell by potentiating with masoprocol
EP0750496A1 (de) * 1994-03-14 1997-01-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Verwendung von lipoxygenase-hemmet als therapeutische und interventions- antikrebsmittel
US6365787B1 (en) * 1994-09-30 2002-04-02 The Johns Hopkins University Compounds for the suppression of HIV TAT transactivation
US5837252A (en) * 1996-07-01 1998-11-17 Larreacorp, Ltd. Nontoxic extract of Larrea tridentata and method of making same
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2785804B1 (fr) * 1998-11-17 2002-10-18 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait de larrea divaricata ou de larrea tridentata pour ralentir le vieillissement cutane
US6787573B2 (en) * 1999-07-02 2004-09-07 Universiteit Utrecht Antiviral therapy
US6214874B1 (en) * 1999-10-15 2001-04-10 John Hopkins University Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N
US6608108B2 (en) 1999-10-15 2003-08-19 Johns Hopkins University Method for treatment of tumors using nordihydroguaiaretic acid derivatives
CN103585136A (zh) * 2003-05-20 2014-02-19 约翰霍普金斯大学 用于治疗肿瘤的邻苯二酚丁烷的释放的方法和组合物
US20060141029A1 (en) * 2003-05-20 2006-06-29 Erimos Pharmaceuticals Llc Methods and compositions for delivery of catecholic butanes for treatment of diseases
US7728036B2 (en) * 2003-05-20 2010-06-01 Erimos Pharmaceuticals, Llc Methods for delivery of catecholic butanes for treatment of tumors
US7420105B2 (en) 2004-03-11 2008-09-02 Carlsberg A/S Barley for production of flavor-stable beverage
CN100440843C (zh) * 2004-05-12 2008-12-03 华为技术有限公司 一种环网及其业务实现方法
RU2006140961A (ru) 2004-05-28 2008-07-10 Юниджен Фармасьютикалз Диарилалканы в качестве эффективных ингибиторов двухъядерных ферментов
US8440648B2 (en) * 2004-07-20 2013-05-14 Erimos Pharmaceuticals Llc Methods and compositions for treatment of intraepithelial neoplasia
CN101150956B (zh) * 2005-01-27 2013-04-17 埃里莫斯医药品有限公司 用于注射入动物的包括ndga化合物的儿茶酚丁烷配方
CA2595617C (en) * 2005-01-27 2014-06-03 Erimos Pharmaceuticals Llc Formulations for injection of catecholic butanes, including ndga compounds, into animals
US20090155349A1 (en) * 2006-02-23 2009-06-18 Jonathan Daniel Heller Methods of treating influenza viral infections
US20070212331A1 (en) * 2006-03-07 2007-09-13 Baldassare Joseph J Methods and compositions for selectively killing cells
EP2076252B1 (de) * 2006-10-02 2014-04-02 Erimos Pharmaceuticals LLC Tetra-substituierte ndga-derivate über etherbindungen und carbamat-bindungen und ihre synthese und pharmazeutische verwendung
US9067875B2 (en) 2006-10-02 2015-06-30 Erimos Pharmaceuticals Llc Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
US8153171B1 (en) * 2007-10-02 2012-04-10 Allen Jay Cohen Solution for dissolving pre-melanoma lesions and melanoma lesions including psoriasis, herpes simplex lesions and eczema lesions
US7597914B1 (en) * 2007-10-02 2009-10-06 Allen Jay Cohen Ala-septic pre-cancerous liquid dissolving solution and method
PL3542780T3 (pl) 2008-07-21 2022-05-02 Unigen, Inc. Szereg związków wybielających (rozjaśniających)
CN109896935A (zh) 2011-03-24 2019-06-18 尤尼根公司 用于制备二芳基丙烷的化合物和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404146A (en) * 1980-12-17 1983-09-13 Biosystems Research Inc. Metal oxyalkylates and method of making same
US4774229A (en) * 1982-04-05 1988-09-27 Chemex Pharmaceuticals, Inc. Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor
AU6330486A (en) * 1986-08-25 1988-03-24 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc
WO1988001509A1 (en) * 1986-08-25 1988-03-10 Chemex Pharmaceuticals, Inc. Pharmacologically active compositions of catecholic butanes with zinc
AU6737987A (en) * 1986-11-19 1988-06-16 Chemex Pharmaceuticals Inc. Pharmacologically active compositions of catecholic butanes with zinc

Also Published As

Publication number Publication date
US4880637A (en) 1989-11-14
AU8172487A (en) 1988-05-25
EP0288534A1 (de) 1988-11-02
EP0288534B1 (de) 1991-12-18
DE3775387D1 (de) 1992-01-30
AU616641B2 (en) 1991-11-07
EP0288534A4 (de) 1989-02-23
KR880701556A (ko) 1988-11-03
WO1988003026A1 (en) 1988-05-05
JPH01501794A (ja) 1989-06-22

Similar Documents

Publication Publication Date Title
ATE70449T1 (de) Zusammensetzungen von katecholischen butanen mit zink.
ES2020011A6 (es) Metodo de sintesis de composiciones que comprenden al menos un butano fenolico.
FR2653336B1 (fr) Composition pharmaceutique et cosmetiques depigmentantes a base d'acide cafeique.
DE69621012D1 (de) VERWENDUNG VON NSAIDs ZUR BEHANDLUNG VON PLATTENEPITHELKARZINOM DER MUNDHÖHLE UND KEHLKOPF
ATE68702T1 (de) Zusammensetzungen zur behandlung von viralen und krebsartigen hautverletzungen und dergleichen.
MY100789A (en) Hair cosmetic composition
SE7611379L (sv) Antihypertensiva medel
ES2181006T3 (es) Uso de amidas de acidos de piridil alcanos, piridil alquenos y/o piridil alquinos en el tratamiento de tumores o en inmunosupresion.
DE3787356D1 (de) Expression von höheren eukaryotischen genen in aspergillus.
DE3751361D1 (de) Verwendung von Hydroxycarbonsäuren zur Verstärkung der therapeutischen Effekte von topischen Zubereitungen gegen Pilzinfektionen und Pigmentflecken.
ES2000036A4 (es) Producto cosmetico a base de n-hidroxipropilquitosanas, nuevas n-hidroxipropilquitosanas, asi como procedimiento para su fabricacion.
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
KR910007536A (ko) 외용 피부 제제
ES8402827A1 (es) Procedimiento para la preparacion de nuevos compuestos de aroilimidazol-2-ona.
DE3780618D1 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
ATE215540T1 (de) Benzofuran-carboxamide und -sulfonamide
ES418227A1 (es) Un procedimiento para producir particulas funcionales fina-mente divididas.
ATE52911T1 (de) Topische anwendung des 3-phenylacetylamino-2,6piperidindionszur behandlung von hautfalten und hyperpigmentierung.
BR8008818A (pt) Peptidos farmacologicamente ativos e medicamentos contendo os mesmos
SE8703210D0 (sv) Hudvardskompositioner med keratolytisk och antiinflammatorisk aktivitet
ES2039578T3 (es) Procedimiento para producir mercapto-acilaminoacidos antihipertensivos.
FR2401187A1 (fr) Nouveaux oligomeres tensio-actifs sequences, procede pour les preparer et compositions les contenant
DE68918280D1 (de) Kosmetische zusammensetzung auf der basis von chromo-carboxylaten.
DE3781116D1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
ES8501380A1 (es) Un procedimiento para preparar l-tiazolidin-4-carboxilato de zinc

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee